“Pacta sunt servanda”

STANDARDIZED - TRANSPARENT - SUSTAINABLE DEVELOPMENT
bt_bb_section_bottom_section_coverage_image
https://brilitas.com/wp-content/uploads/2020/03/blue_triangle_01-1.png
EUROPEAN DATABASE ON MEDICAL DEVICES
Authorised Representative at EUDAMED since 2023
COSMETIC PRODUCT NOTIFICATION PORTAL
Registered at CPNP since 2023
EUROPEAN MEDICINES AGENCY
Registered at EMA since 2023
EU TRANSPARENCY REGISTER
Registered at EU TRANSPARENCY REGISTER since 2023
EUROPEAN FOOD SAFETY AUTHORITY
Registered at EFSA since 2023

About UsBrilitas Pharmaceuticals ("Brilitas")

is the multinational corporation servicing in health sector, mainly specialized in research, development, innovation, manufacture, and distribution of molecular & quantum biological products for human health, providing Medical Services on medicines, medical devices, in-vitro medical devices, supplements and cosmetics, standardized by regulations and standards of European Commission, with the aim of bringing the best experience to Clients and Patients on using medical products and services of Brilitas, and for the positive contribution of sustainable development of human health.

Brilitas is registered with the following Europe Commission agencies:

  • EUROPEAN MEDICINES AGENCY (EMA)
  • EUROPEAN DATABASE ON MEDICAL DEVICES (EUDAMED) No. EE-AR-000032004
  • EU COSMETIC PRODUCT NOTIFICATION PORTAL
  • EU TRANSPARENCY REGISTER No. 413055049244-08
  • EUROPEAN FOOD SAFETY AUTHORITY
https://brilitas.com/wp-content/uploads/2020/06/large_blue_triangle_04-1.png
https://brilitas.com/wp-content/uploads/2020/04/home_experience_01-2.jpg
https://brilitas.com/wp-content/uploads/2020/04/home_experience_02-2.jpg
https://brilitas.com/wp-content/uploads/2020/04/home_experience_03-2.jpg
https://brilitas.com/wp-content/uploads/2020/04/home_experience_04-2.jpg
https://brilitas.com/wp-content/uploads/2020/04/experience_01-3.png

VALUES - COMMITMENT - STRENGTHS

By approvals from European Commission and its agencies, Brilitas becomes the full licensed corporation to be granted comprehensive rights of research, pre-clinical & clinical evaluation, registration, import & export, administration, storage, distribution and tendering in medicines, medical devices, in-vitro diagnostic medical devices, supplements and cosmetics, to offer Agencies, Partners and Clients of Brilitas a wide entrance to European Union and international market where Brilitas has its commercial presence and System of Agency & Partner Networks.
https://brilitas.com/wp-content/uploads/2020/06/large_blue_triangle_03-1.png
https://brilitas.com/wp-content/uploads/2020/03/blue_triangle_01-1.png

ADVANTAGESBRILITAS IS THE FIRST AND ONLY COMPANY IN THE WORLD TO BE GRANTED ALL RIGHTS

BY THE EUROPEAN COMMISSION IN RELATING TO DRUGS, MEDICAL DEVICES, IN VITRO DIAGNOSTIC DEVICES, SUPPLEMENTS AND COSMETICS.
Recognized by a transparent organization in the EU
After the product is successfully registered by Brilitas EU, it will be distributed worldwide.
Low cost and many incentives, register a brand in the EU from only 15,000 USD
Brilitas has a team of leading technical and legal advisors in the world
Professional and enthusiastic staff
https://brilitas.com/wp-content/uploads/2020/06/home_experience_06-1.jpg
https://brilitas.com/wp-content/uploads/2020/06/home_experience_07-1.jpg
https://brilitas.com/wp-content/uploads/2020/06/home_experience_08-1.jpg
https://brilitas.com/wp-content/uploads/2020/06/home_experience_09-1.jpg
https://brilitas.com/wp-content/uploads/2020/06/experience_10-1.png
https://brilitas.com/wp-content/uploads/2020/06/large_blue_triangle_01-1.png
bt_bb_section_top_section_coverage_image